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SUMMARY
The domestic dog is the reservoir host of Leishmania infantum, the causative agent of zoonotic visceral leishmaniasis
endemic in Mediterranean Europe. Targeted control requires predictive risk maps of canine leishmaniasis (CanL), which
are now explored. We databased 2187 published and unpublished surveys of CanL in southern Europe. A total of 947
western surveys met inclusion criteria for analysis, including serological identiﬁcation of infection (504, 369 dogs tested
1971–2006). Seroprevalencewas 23·2% overall (median 10%). Logistic regressionmodels within aGIS framework identiﬁed
the main environmental predictors of CanL seroprevalence in Portugal, Spain, France and Italy, or in France alone.
A 10-fold cross-validation approach determined model capacity to predict point-values of seroprevalence and the correct
seroprevalence class (<5%, 5–20%, >20%). Both the four-country and France-only models performed reasonably well for
predicting correctly the <5% and >20% seroprevalence classes (AUC >0·70). However, the France-only model performed
much better for France than the four-country model. The four-country model adequately predicted regions of CanL
emergence in northern Italy (<5% seroprevalence). Both models poorly predicted intermediate point seroprevalences
(5–20%) within regional foci, because surveys were biased towards known rural foci and Mediterranean bioclimates. Our
recommendations for standardizing surveys would permit higher-resolution risk mapping.
Key words: canine leishmaniasis, western Mediterranean, predicting distribution, serological records, seroprevalence.
INTRODUCTION
Zoonotic visceral leishmaniasis (ZVL) is endemic in
Mediterranean Europe, where the causative agent
Leishmania infantum is transmitted by phlebotomine
sandﬂies of the subgenus Phlebotomus (Larroussius)
(Ready, 2010), but its surveillance and control are
neglected compared with research eﬀorts (Dujardin
et al. 2008). There are estimated to be only 700 new
human cases of ZVL per year in southern Europe
(Dujardin et al. 2008), and some people develop
cutaneous lesions. However, the seroprevalence in
the domestic dog, the only proven reservoir host
(Quinnell and Courtenay, 2009), is often 20%
(Dujardin et al. 2008), suﬃciently high to pose a
serious risk of re-emergence of human disease,
especially in immuno-suppressed people (Ready,
2010). Human cases are not usually infectious to
sandﬂy vectors, but the parasite has been exported
fromEurope in the canine reservoir hosts, historically
to Latin America where it now causes much fatal
infantile disease (Romero and Boelaert, 2010) and
recently even to North America in fox hounds
(Duprey et al. 2006).
The control of canine leishmaniasis (CanL) is
considered to be the best way of reducing the
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incidence of human disease in ZVL foci (Quinnell
and Courtenay, 2009) and one way of controlling any
spread northwards in Europe (Ready, 2010).
Targeted control would be assisted by predictive
risk maps of CanL, but unfortunately these do
not exist, even in Europe where there have been
numerous surveys and incidence has beenmapped for
positive point locations or administrative areas
(Trotz-Williams andTrees, 2003).The current report
investigates the challenges of producing a predictive
risk map of CanL for western Europe, based on the
authors’ databasing of historical records of CanL
during the EU EDEN project (Emerging Diseases in
a changing European eNvironment; http://www.
eden-fp6project.net). Records for Eastern Europe
were included in our database, but they are not
analysed in the current report because they are
relatively few in number and the transmission cycles
are biogeographically distinct (Ready, 2010). Only 2
sandﬂies, Phlebotomus perniciosus and P. ariasi, have
been incriminated as vectors in Portugal, Spain and
France, and the former is also the most widespread
vector in Italy,whereP.perﬁliewi andP.neglectuspose
regional threats. Further east, the vectors are
P. perﬁliewi, P. neglectus and P. tobbi.
Of all the CanL records we found in the literature
and personal ﬁles, only those from random surveys
of dog populations were targeted for our risk
mapping, in order to lessen the chances of analysing
populations of mixed geographical origins, including
travel cases, or biasing prevalence estimates by
missing asymptomatic seropositive dogs. Multi-
variate logistic regression models were built, using a
GIS framework, to ﬁnd the main predictors of CanL
prevalence in western Europe or France alone based
on a range of variables, including remotely-sensed
climatological and vegetation indices.
MATERIALS AND METHODS
Developing a European database of CanL
The EDEN subproject on leishmaniasis developed
a database of all surveys of CanL carried out in
Europe and other Mediterranean countries from
1965. A standardized Microsoft® Oﬃce Excel work-
sheet included information related to: publication or
dataset; survey type, date, location and environment;
method of selecting dogs to be screened; method(s)
of diagnosis of infection; dog travel history, breed,
age and lifestyle; number of dogs tested and number
positive.
For the present study, the data-gathering teams
in Portugal (1), Spain (3), France (1) and Italy (1)
performed a systematic search for published and
unpublished reports in their regions, based on their
expert knowledge of data sources. Data entries were
standardized by the analytical team in the UK, based
on clariﬁcations provided by the data gatherers. The
present analysis included only surveys that provided
estimates of CanL prevalence based on serological
diagnosis. Surveys were excluded from the analysis if
1 or more of the following criteria applied: CanL
prevalence could not be estimated either directly or
indirectly; the method of diagnosis was not serologi-
cal (but was based solely on clinical signs, microscopy
or molecular characterization); dogs were clearly not
sampled ‘randomly’ from a settlement or adminis-
trative unit (excluded were positive cases reported by
veterinary clinics or other cases possibly associated
with passive detection and unknown combinations of
localities); data were duplicated and reported more
completely in another publication; location was
missing or unable to be geo-positioned; and, environ-
mental data were lacking.
Only a minority of reports included geographical
coordinates. Most records mentioned the nearest
settlement, which was geo-positioned using Google
Earth (http://earth.google.com; accessed 2 February
2009). The survey date was potentially an explana-
tory variable, and so it was derived by (a) averaging
the survey’s start and end years, or (b) using one
of those two dates if the other was missing, or
(c) using the year of publication if survey dates were
not reported.
Environmental data
Data for long-term climatic averages (based on the
period 1961–1990) of monthly precipitation, relative
humidity, mean temperature and mean diurnal
temperature range were obtained at a spatial resol-
ution of 10 arc-minutes from the Climatic Research
Unit, University of East Anglia, UK (New et al.
2002). Monthly data were aggregated into averages
for the warmmonths (May to September) and for the
cold months (October to April). Remotely sensed
(MODIS v4), Fourier-processed data (Rogers et al.
1996) for day-time (LSTD) and night-time (LSTN)
land surface temperature, middle infrared reﬂectance
(MIR) and Enhanced vegetation index (EVI) for
the period 2001–2005 were produced by Professor
David Rogers and his team (Spatial Ecology and
Epidemiology Research Group, Department of
Zoology, Oxford University) and obtained from the
EDEN project data archive (http://ergodd.zoo.ox.ac.
uk/EDEN/index.php?p=1; accessed 2 March 2009).
These data have a spatial resolution of 1 km (250m
for EVI) and include separate products relating to the
means, amplitudes and phases of annual, biannual
and tri-annual cycles. Elevation data were derived
from the GLOBE digital elevation model (spatial
resolution 1 km) (US National Geophysical Data
Center (NGDC), National Oceanic & Atmospheric
Administration (NOAA) Satellite and Information
Service. Available: http://www.ngdc.noaa.gov/; ac-
cessed 2 March 2009).
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Statistical model building
CanL seroprevalence was modelled as a binomial
variate: the number of dogs examined and dogs found
exposed to Leishmania infection at each survey
location. To overcome the dependency of obser-
vations at the same location, the association between
risk of exposure to infection and the environmental
covariates was determined using ﬁxed-eﬀects
grouped logistic regression with robust standard
errors (Rogers, 1993; Rabe-Hesketh and Everitt,
2004) in the statistical package Stata (version 10;
StataCorp, College Station, Texas, USA). Binary
logistic regression (logit command in Stata) is more
frequently used for statistical modelling, but this
would have required splitting CanL seroprevalence
into 2 categories and, thereby, losing information
(Rabe-Hesketh and Everitt, 2004). In addition,
global spatial structures within the seroprevalence
data and among model Pearson residuals from
multivariate regression analysis were evaluated
using semivariograms estimated using the R module
GeoR (Ribeiro and Diggle, 2001). Semivariograms
show the spatial dependence of the variable of interest
as a scatter plot, and as such provide a means of
assessing visually the presence of spatial autocorrela-
tion (Pullan et al. 2008).
Prior to multivariate analysis, univariate binomial
logistic regression analyses were carried out to test for
associations between seroprevalence and each of the
46 environmental variables, as well as the potentially
confounding variable of the survey country.
Predictors that were signiﬁcant at the 10% probability
level were retained. The uncentred variance inﬂation
factor (VIF) was used to screen for co-linearity
between the retained environmental continuous
variables (Rabe-Hesketh and Everitt, 2004). Within
a group of themed environmental variables, those
with VIF 510 were excluded one by one. The
procedure was repeated to test for co-linearity
between the variables of diﬀerent groups. The
remaining variables were included in a multivariate
binomial logistic regression model, for which a
backward stepwise selection procedure was per-
formed, excluding the variables with the highest
Wald test P-value until all the variables in the model
had P<0·05.
Some of the variables retained in the model were
non-linear, and these were transformed if this im-
proved the model ﬁt. We found the best transform-
ation for each predictor, startingwith the onewith the
smallest P-value in the linear model, and then
transforming the predictor with the next smallest
P-value. The non-linearity of each variable (x) was
explored by a quadratic polynomial transformation
and by 7 fractional polynomial transformations
of the ﬁrst degree (FPs), namely 1/x2, 1/x, 1/x0·5,
ln(x), x0·5, x2, and x3 (Royston et al. 1999; Hosmer
and Lemshow, 2000). The best-ﬁt transformation is
the one that produces the largest reduction in the
residual deviance. The quadratic polynomial trans-
formation was selected if it decreased deviance by
more than 5·99 compared with the best ﬁt FP.
Otherwise, the best ﬁt FP was selected if it decreased
deviance by more than 3·84 compared with the linear
(i.e. untransformed) variable. If the decrease in
deviance was less, then the variable remained linear.
This process was repeated several times until
no further FP transformations were indicated for
the multivariate model without clustering, and then
the same transformation was applied when ﬁtting the
ﬁnal model with clustering (Hosmer and Lemshow,
2000).
The same method was used to build 2 additional
models. For the four-country dataset, a separate
model included diagnostic method and survey year,
to assess whether they improved the accuracy of the
model predictions. A separate model was also built
for the data from France alone, in order to investigate
better any eﬀect of country on accuracy.
Model validation
The predictive performance of each model was
assessed by using a 10-fold cross-validation approach
(Hastie et al. 2001; Tibshirani et al. 2002). Brieﬂy,
the CanL seroprevalence dataset was split randomly
into 10 approximately equal-sized parts. The ﬁnal
multivariate logistic model was ﬁtted on 90% of the
data points, and then used to predict the seropreva-
lence of the remaining 10% (the validation set). This
procedure was performed 10 times, each time with 1
of the 10 dataset parts acting as the validation set. The
seroprevalences predicted by all the validation sets
were then compared with the observed values for the
same locations. For each of the validation sets the
predictive performance of the model was tested by
determining the capacity of the model to predict
either point-values of seroprevalence – using the
correlation coeﬃcient as a measure of linear associ-
ation between the predicted and the observed values
(Gething et al. 2008; Hay et al. 2009) – or the correct
endemicity class. Three endemicity classes were
considered: low (<5% seroprevalence), medium
(5–20%), and high risk (>20%). The capacity of the
model to predict the correct endemicity class
was assessed using the area-under-curve (AUC) of
a receiver-operating-characteristic (ROC) curve,
which plots sensitivity versus one minus speciﬁcity
for each endemicity class (Brooker et al. 2002; Hay
et al. 2009). AUC values indicate the agreement
between the observed and predicted endemicity class:
poor, 0·51–0·70; reasonable, 0·71–0·90; and excel-
lent, >0·9 (Brooker et al. 2002; Hay et al. 2009). The
prediction accuracy was further assessed by a
contingency table and by calculating the percentage
of points classiﬁed in the correct endemicity class or
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in a non-adjacent class (Hay et al. 2009). The
validation statistics for all 10 dataset parts were
averaged to compute the overall accuracy of the
predictions.
Producing a risk map of CanL seroprevalence
Each statistical model was then used to estimate
CanL seroprevalence for a country, based on the
predictor values available from remotely sensed
images for a 1 km-square grid. Finally, the predicted
CanL risk was converted into 1 of 5 endemicity
classes: low (<5% seroprevalence), medium-low
(5–10%), medium-high (10·01–20%), high (20·01–
30%) and very high risk (>30%), and the predicted
seroprevalence was mapped using ArcGIS v. 9.2
(ESRI, Redlands, CA, USA). Seroprevalence was
mapped only for the pixels where the environmental
values were within the range of those in the survey
locations.
RESULTS
Database of CanL in Europe
The historical CanL database included cross-
sectional surveys, prospective surveys, laboratory
records, cases reported at veterinary clinics and case
reports. It contained 2187 surveys, including 33 from
Croatia, 26 from Greece and 55 from Turkey. There
was a total of 2073 reports from Portugal, Spain,
France and Italy, of which 947 (45·7%) were included
and 1126 were excluded from the current analysis
based on the criteria reported above. The most
frequent exclusion reasons were non-random
sampling (n=849; 75·4%), missing data for the
number of dogs tested or positive (n=595; 52·8%)
and non-serological diagnosis (n=258; 22·9%). Of the
latter, 117 were solely based on microscopy, 58 on
culture, 47 on molecular characterization, and 36 on
clinical signs. The datasets with the included and
excluded CanL seroprevalence surveys can be ob-
tained from the corresponding author.
The remaining 947 surveys were analysed, and the
reports included 124 publications. The surveys were
undertaken between 1971 and 2006 inclusive (75%
after 1985, and 50% after 1992) and involved 504369
dogs tested for exposure to Leishmania infections.
The data analysed are summarized in Table 1 and
mapped in Fig. 1. Of the analysed surveys, most were
conducted in Italy (377; 40%), followed by Spain
(213; 22%), Portugal (188; 20%) and France (169;
18%). The median number of dogs tested per survey
was 67, being highest in Italy (168) and lowest in
Spain (39). The frequency distribution of the
number of dogs per survey was highly right skewed,
with the maxima being 30001 for Italy, 7067 for
France, 1803 for Spain and 1024 for Portugal.
Surveys were conducted between latitudes 35·5°
and 47·5° North and longitudes 9·3° West and 17·6°
East. The analysed records covered altitudes of
1–1838m above sea level (median 204m a.s.l.).
Most surveys (99%) were conducted below 1000m
a.s.l. (3 at 1000–1500m a.s.l. in France; and 6 at
1000–1500m a.s.l. and 1 at 1838m a.s.l. in Spain).
The diagnostic method most commonly used was the
indirect ﬂuorescent antibody test (IFAT), both
overall (77%) and in each country, and the most
frequent IFAT cut-oﬀ was equal to or above the
current minimum standard of 1:80. The proportion
of surveys using an IFAT cut-oﬀ <1:80 was 35·4%
in Italy, 19·2% in Portugal, 2·4% in Spain and 0% in
France. The other serological diagnostic methods
most frequently used were ELISA, DOT-ELISA
and the direct antibody test (DAT).
The overall CanL seroprevalence was 23·2%
(116,968/504,369), and 5% of the surveys recorded
seroprevalences >40%. Point seroprevalences >80%
were recorded in Italy, Portugal and Spain, but the
maximum in France was only 43%. The median
seroprevalence was 10%, being highest in Italy
(17·7%), followed by France (8%), Portugal (7·3%)
and Spain (5·9%). Zero seroprevalences were re-
corded in 14·7% of the surveys, being more frequent
in Spain (25%), followed by Portugal (20%), France
(14%), and Italy (6%).
Statistical models
Four-country model. Among the 49 variables
screened by univariate analysis (Table 2), 32 were
signiﬁcantly associated with CanL seroprevalence
at the 10% probability level: diagnostic method,
survey year, country, altitude, latitude, 21 Fourier-
transformed remotely sensed (RS) variables from
4 environmental groups, and 6 variables from 4
climatic groups. Of the latter 27 variables, 19 were
excluded due to co-linearity, leaving 11 variables to
be tested for inclusion in the multivariate model.
These consisted of country, altitude, latitude and
8 Fourier-transformed RS variables relating to
night-time land surface temperature (minimum
(LSTNmn), amplitude of the tri-annual cycle
(LSTNa3)), day-time land surface temperature
(amplitude of the bi-annual cycle (LSTDa2), phase
of the tri-annual cycle (LSTDp3)), and enhanced
vegetation index (minimum (EVImn), amplitude of
the annual cycle (EVIa1), and phases of the annual
and tri-annual cycles (EVIp1, EVIp3)). Of these,
7 variables remained in the ﬁnal multivariate model
(Table 3). The association with seroprevalence was
inversely U-shaped for some predictors (i.e. the
highest seroprevalence was observed at intermediate
values), namely altitude, LSTNmn, LSTNa3 and to
amuch lesser degree EVIp1, and so all were usedwith
a quadratic transformation. When testing for the
confounding eﬀect of diagnostic method and survey
year, only the latter dropped from the multivariate
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Table 1. Seroprevalences of canine leishmaniasis and number of dogs tested for all surveys analysed
No. surveys
All countries (n=947) France (n=169) Italy (n=377) Portugal (n=188) Spain (n=213)
Prevalence % Prevalence % Prevalence % Prevalence % Prevalence %
Survey category Median (Range) Median (Range) Median (Range) Median (Range) Median (Range)
Total 10·0 (0–100) 100a 8·0 (0–43·3) 17·8a 17·7 (0–100) 39·8a 7·3 (0–81·1) 19·9a 5·9 (0–100) 22·5a
Survey year
1971–1980 6·3 (0–100) 13·8 4·4 (0–40·0) 42·6 11·1 (0–100) 12·5 0·0 (0–3·6) 6·4 — (—) —
1981–1990 10·2 (0–66·7) 28·9 13·2 (0·7–43·3) 14·8 19·1 (2·5–66·7) 9·3 10·4 (0–39·8) 57·4 6·9 (0–45·5) 49·8
1991–2000 11·7 (0–100) 45·0 9·1 (0–27·6) 34·9 21·1 (0–100) 53·6 6·3 (0–81·1) 33·0 5·2 (0–100) 48·4
2001–2006 11·1 (0–100) 12·2 11·1 (4·1–17·7) 7·7 10·7 (0–100) 24·7 17·6 (0–21·4) 3·2 16·9 (3·8–66·1) 1·9
Altitude
1–<100 12·5 (0–100) 32·4 7·3 (0–43·3) 28·4 16·8 (0–100) 44·8 7·1 (0–34·1) 35·6 5·9 (0–34·6) 10·8
100–<500 11·5 (0–100) 45·1 9·4 (0–40·0) 45·6 20·0 (0–100) 46·4 10·1 (0–80·0) 43·6 9·1 (0–66·1) 43·7
500–<1000 5·6 (0–100) 20·3 7·3 (0–23·7) 21·3 20·0 (0·4–80·0) 7·7 4·5 (0–81·1) 19·7 4·3 (0–100) 42·3
1000–<1500 5·0 (0–11·1) 1·0 0·0 (0–5·0) 1·8 — (—) — — (—) — 6·4 (0–11·1) 1·0
1500–1838 12·3 (12·3–12·3) 0·1 — (—) — — (—) — — (—) — 12·3 (12·3–12·3) 0·1
Diagnostic
IFAT 11·3 (0–100) 76·6 4·8 (0–43·3) 64·5 18·4 (0–100) 96·6 8·3 (0–39·8) 66·5 4·4 (0–100) 59·6
ELISA 11·1 (0–100) 8·4 11·1 (0–27·6) 34·9 24·4 (7·1–100) 1·1 6·5 (6·5–6·5) 0·5 13·0 (0–34·1) 7·5
Dot ELISA 7·7 (0–36·4) 7·3 — (—) — — (—) — — (—) — 7·7 (0–36·4) 32·4
DAT 6·6 (0–81·1) 5·8 25·7 (25·7–25·7) 0·6 — (—) — 6·3 (0–81·1) 28·7 — (—) 0·0
Otherb 4·0 (0–66·1) 1·9 — (—) — 1·6 (0–37·1) 2·4 6·1 (0–15·8) 4·3 66·1 (66·1–66·1) 0·5
No. dogs tested All countries (n=504369) France (n=39259) Italy (n=423831) Portugal (n=15896) Spain (n=25383)
Median (Interquartile
Range)
%c Median (Interquartile
Range)
%c Median (Interquartile
Range)
%c Median (Interquartile
Range)
%c Median (Interquartile
Range)
%c
No. dogs tested
/survey
67 (31–209) 100 60 (32–112) 7·8 168 (43–612) 84·0 52 (34–104) 3·2 39 (20–93) 5·0
a Percentage of surveys out of the total of surveys in all countries. Percentages for categories total 100%, except for altitude because this was not found for 11 surveys (5 in France, 4 in Italy and 2 in Portugal).
b Including CIE, IFAT and CIE, LST. [IFAT: Indirect Fluorescence Antibody Test. ELISA: Enzyme-Linked Immunosorbent Assay. DAT: Direct Agglutination Test. CIE: Counter-
immunoelectrophoresis. LST: Leishmanin Skin Test].
c Percentage of dogs tested calculated out of the total of dogs tested in all countries.
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model. However, diagnostic method was not re-
tained, because it did not substantially improve the
accuracy of the model predictions. Semivariograms
were estimated on the basis of both observed
prevalence and Pearson residuals from multivariate
models, to investigate the removal of spatial trends
potentially related to environmental variables. Both
analyses produced unbounded semivariograms (not
shown) in which semivariance increased steadily with
increasing distance (spatial lags) between obser-
vations. In the absence of any clear spatial structure
in the prevalence data, modelling was restricted to a
non-spatial regression analysis. The ﬁnal model
equation was: CanL seroprevalence=(exp(p)/(1+
exp(p)) × 100; where p =− 2·67413− 0·5203425 ×
country_2 − 1·486901 × country_3 − 1·627514 ×
country_4 + 0·0015933 × altitude− 8·76 × 10− 7 ×
(altitude)2 + 0·1632941 × LSTNmn− 0·0167179 ×
(LSTNmn)2 + 4·346963 × LSTNa3− 2·562916 ×
(LSTNa3)2 + 0·0874507 × 1/
√
EVIa1 + 0·136483 ×
EVIp1 − 0·0361457 × (EVIp1)2 − 0·1942139 ×
(1/EVIp3); and where country_2, country_3 and
country_4 were dummy variables for Italy, Portugal
and Spain, respectively.
France-only model. Following the samemethod, the
only variables remaining in the ﬁnal multivariate
model were altitude, LSTNmn, amplitude of the bi-
annual cycle of the night-time land surface tempera-
ture (LSTNa2), LSTNa3, amplitude of the annual
cycle of middle infrared reﬂectance (MIRa1)
and amplitude of the tri-annual cycle of middle
infrared reﬂectance (MIRa3) (Table 4). The ﬁnal
model equation was: CanL seroprevalence=(exp(p)/
(1+exp(p))×100; where p=−5·849738+0·0526301×√
altitude +32·16849×MIRa1−129·4284×MIRa3+
1·429675 × 1/
√
LSTNa2 + 1·130128 × LSTNa3 +
0·2185278×LSTNmn.
Validation of four-country model
This was performed with 931 surveys, because at
least 1 of the environmental variables in the model
was missing for 16 records (5 in France, 8 in Italy and
3 in Portugal).
Predicting point-values of CanL seroprevalence:
The global correlation coeﬃcient (r) between the
predicted and observed seroprevalences was 0·341,
and the weakness of this linear agreement was clear in
a scatter plot. Predicted seroprevalences were con-
centrated at 440%, while observed seroprevalences
ranged from 0 to 100%. The overall ﬁt did not
improve signiﬁcantly (r=0·352) if only the observed
seroprevalences 440% (95% of records) were con-
sidered. The country level correlation was consider-
ably stronger for Italy (r=0·432), which had about
twice as many surveys as the other 3 countries
(r=0·233–0·262).
Predicting endemicity classes of CanL seropreva-
lence: When comparing the model predictions with
the observed seroprevalences in the 931 surveys, 41%
of the records were correctly classiﬁed to 1 of the 3
endemicity classes (Italy: 48%; Spain: 40%; Portugal:
37%; France: 32%). Only 5·5% were misclassiﬁed to a
non-adjacent class (Italy: 3·8%; Spain: 4·2%;
Portugal: 2·2%; France: 14·6%). Overall AUC stat-
istics for the two extreme seroprevalence classes
(<5%, >20%) exceeded the 0·7 threshold for fair to
Fig. 1. Distribution of all 947 serological surveys of canine leishmaniasis included in the analyses and modelling of its
seroprevalence.
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Table 2. Univariate binomial logistic regression analyses to test associations between seroprevalence of
canine leishmaniasis in the four countries and each potential explanatory variable
Variable No./947 Range Odds Ratio
(95% conﬁdence
intervals) P-value
Country France 169 1·00 <0·00001*
Italy 377 1·02 (0·689–1·518)
Portugal 188 0·38 (0·247–0·571)
Spain 213 0·34 (0·221–0·519)
Diagnostic Dot ELISA 69 1·00 <0·00001*
IFAT 725 3·91 (2·331–6·569)
ELISA 80 1·56 (0·910–2·666)
DAT 55 1·12 (0·620–2·014)
Other (Table 1) 18 0·21 (0·118–0·392)
Surv. date 947 (1971–2006) 1·02 (1·001–1·047) 0·044*
Latitude 947 (35·5011–47·5267) 0·90 (0·840–0·966) 0·004*
Altitude 936 (1–1838) 1·00 (0·999–1·000) 0·074*
MIRa MIRa0 947 (0–0·243) 2·34 (0·105–52·276) 0·591
(Middle MIRa1 947 (0–0·104) 20·76 (0·006–73975·1) 0·467
Infrared MIRa2 947 (0–0·034) 8·36×10−11 (3·12×10−26–2·24×105) 0·200
Reﬂectance) MIRa3 945 (0–0·017) 8·87×108 (1·11×10−8–7·07×1025) 0·299
MIRmn 947 (0–0·187) 0·97 (0·011–86·242) 0·990
MIRmx 947 (0–0·317) 2·84 (0·277–29·118) 0·380
MIRp1 947 (0–7·620) 1·32 (1·097–1·580) 0·003*
MIRp2 947 (0–5·710) 1·01 (0·959–1·069) 0·658
MIRp3 947 (0–3·960) 1·02 (0·868–1·201) 0·805
LSTDa LSTDa0 938 (11·96–29·58) 1·04 (0·985–1·102) 0·153
(Day-time LSTDa1 941 (5·48–17·36) 0·88 (0·822–0·935) 0·0001*
land LSTDa2 941 (0·20–3·08) 0·73 (0·565–0·950) 0·019*
surface LSTDa3 941 (0·06–1·78) 1·09 (0·652–1·820) 0·744
temperature) LSTDmn 940 (−15·22–17·18) 1·15 (1·096–1·199) <0·00001*
LSTDmx 938 (22·56–46·08) 0·98 (0·946–1·011) 0·187
LSTDp1 940 (6·07–7·00) 8·15 (4·070–16·321) <0·00001*
LSTDp2 941 (0·61–3·10) 0·62 (0·442–0·856) 0·004*
LSTDp3 941 (0·03–3·98) 1·20 (1·017–1·428) 0·0313*
LSTNa LSTNa0 938 (3·98–15·56) 1·10 (1·045–1·169) 0·0005*
(Night-time LSTNa1 941 (5·10–11·80) 0·83 (0·742–0·919) 0·0004*
land LSTNa2 941 (0·10–2·24) 1·07 (0·830–1·381) 0·599
surface LSTNa3 941 (0·04–1·64) 1·86 (1·166–2·967) 0·009*
temperature) LSTNmn 938 (−7·40–9·90) 1·11 (1·071–1·156) <0·00001*
LSTNmx 938 (13·76–26·78) 1·07 (1·010–1·129) 0·021*
LSTNp1 940 (6·41–7·26) 28·73 (11·335–72·810) <0·00001*
LSTNp2 941 (0·03–5·86) 0·51 (0·333–0·790) 0·003*
LSTNp3 941 (0·14–2·91) 0·98 (0·745–1·292) 0·891
EVIa EVIa0 945 (−0·035–0·430) 0·18 (0·056–0·610) 0·006*
(Enhanced EVIa1 945 (0·002–0·247) 0·01 (6·86×10−5–0·792) 0·040*
vegetation EVIa2 922 (0·002–0·085) 0·01 (2·32×10−7–6·93×10−2) 0·433
Index) EVIa3 944 (0·001–0·054) 5·27×10−6 (5·00×10−16–5·55×104) 0·302
EVImn 945 (−0·093–0·371) 0·24 (0·044–1·286) 0·095*
EVImx 945 (0·005–0·653) 0·34 (0·129–0·911) 0·032*
EVIp1 945 (0·530–10·530) 0·90 (0·827–0·974) 0·010*
EVIp2 945 (0·040–5·920) 0·83 (0·747–0·913) 0·0002*
EVIp3 945 (0·040–3·990) 1·21 (1·078–1·349) 0·001*
Climateb DTR summer 925 (5·98–16·20) 0·85 (0·817–0·893) <0·00001*
DTR winter 925 (4·79–11·50) 0·84 (0·789–0·897) <0·00001*
TMP summer 925 (11·36–23·50) 1·18 (1·070–1·295) 0·001*
TMP winter 925 (0·63–14·77) 1·17 (1·108–1·244) <0·00001*
PRE summer 925 (9·12–107·98) 0·98 (0·971–0·988) <0·00001*
PRE winter 925 (28·30–146·40) 1·00 (0·989–1·001) 0·126
REH summer 925 (38·30–62·42) 1·05 (1·031–1·078) <0·00001*
REH winter 925 (61·90–86·20) 1·01 (0·951–1·070) 0·767
a The last 2 characters denote the output from Fourier processing:−a0: mean, mn: minimum, mx: maximum, a1: ampli-
tude of annual cycle, a2: amplitude of bi-annual cycle, a3: amplitude of tri-annual cycle, p1: phase of annual cycle, p2: phase
of bi-annual cycle, p3: phase of tri-annual cycle; b DTR: diurnal temperature range, TMP: mean temperature, PRE:
rainfall, REH: relative humidity, summer: May-September, winter: October-April; * P <0·1 in the univariate analysis.
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good discrimination (AUC=0·71 and 0·73, respec-
tively), but theAUCfor the intermediate class (5–20%)
was below the threshold (AUC=0·55).When looking
at the results by country, similar results applied
to France and Italy, where the model performed
best, while in Portugal and Spain the AUC for all
CanL seroprevalence classes was below 0·6.
Validation of France-only model
This was performed with 164 of the 169 surveys
carried out from 1971 to 2006, because at least 1 of the
environmental variables in the model was missing for
5 records.
Predicting point-values of CanL seroprevalence:
The global correlation coeﬃcient (r) between the
predicted and observed seroprevalences was 0·648.
The range of predicted seroprevalences was 2–38%,
which is comparable to the observed range of 0–43%.
Predicting endemicity classes of CanL seropreva-
lence: When comparing the model predictions
with the observed seroprevalences in the 164 surveys,
54% of the records were correctly classiﬁed to 1 of
the 3 endemicity classes, substantially more than
those correctly classiﬁed for France (32%) by the
four-country model. Only 3% were misclassiﬁed to a
non-adjacent class, substantially fewer than those
misclassiﬁed for France (14·6%) by the four-country
Table 3. Multivariate binomial logistic regression analysis of the associations between seroprevalence of
canine leishmaniasis and each explanatory variable (or risk factor) for the four-country model
Explanatory
variable Category Ref. point
No. dogs
tested
No.
surveys
Mean
prevalence
(Standard
deviation) ORb (95% Cl)c
Country France 39259 169 10·3 (9·9) 1·00
Italy 423831 377 20·6 (17·8) 0·59 (0·40–0·87)
Portugal 15896 188 12·0 (13·6) 0·23 (0·14–0·37)
Spain 25383 213 9·5 (12·0) 0·20 (0·13–0·31)
Altitude 1–99 50 390292 307 15·7 (15·3) 1·00
100–499 300 74578 427 15·8 (15·5) 1·38 (1·18–1·61)
500–999 750 32297 192 10·6 (15·1) 1·87 (1·27–2·74)
1000–1838 1400 1906 10 5·3 (4·9) 1·55 (0·74–3·25)
LSTNmna −7·40–0·34 −4·00 36642 191 11·7 (16·0) 1·00
(Night-time −0·33–1·10 0·40 148263 183 12·0 (14·6) 2·67 (1·89–3·78)
land surface 1·11–2·30 1·70 78823 190 18·3 (17·2) 3·16 (2·05–4·88)
temperature) 2·31–4·40 3·50 142838 188 14·5 (13·8) 3·62 (2·14–6·15)
4·41–9·90 7·00 92977 186 15·4 (13·7) 3·47 (1·89–6·38)
LSTNa3a 0·04–0·30 0·15 16231 211 10·1 (10·0) 1·00
(Night-time 0·31–0·37 0·35 20283 156 11·3 (13·5) 1·85 (1·27–2·68)
land surface 0·38–0·50 0·45 43745 206 12·0 (14·0) 2·32 (1·40–3·87)
temperature) 0·51–1·00 0·75 354105 338 20·1 (17·9) 3·40 (1·78–6·49)
1·01–1·64 1·15 65376 30 16·1 (15·5) 2·76 (2·52–3·02)
EVIa1a 0·002–0·025 0·015 330482 234 15·8 (15·0) 1·00
(Enhanced 0·026–0·050 0·030 104380 322 14·9 (15·7) 0·81 (0·71–0·98)
vegetation 0·051–0·075 0·045 22709 179 15·2 (16·8) 0·74 (0·61–0·95)
Index) 0·076–0·100 0·065 21528 98 14·0 (14·8) 0·69 (0·54–0·93)
0·101–0·247 0·165 25097 112 10·0 (12·5) 0·61 (0·44–0·89)
EVIp1a 0·53–3·00 1·5 18641 180 14·4 (17·3) 1·00
(Enhanced 3·01–4·50 3·5 28261 91 15·4 (16·0) 0·92 (0·61–1·38)
vegetation 4·51–6·00 5·5 186709 280 15·6 (14·7) 0·63 (0·36–1·10)
Index) 6·01–7·00 6·5 268213 362 13·9 (15·0) 0·47 (0·28–0·79)
7·01–10·53 8·5 2372 32 10·5 (10·8) 0·21 (0·16–0·27)
EVIp3a 0·40–0·70 0·50 89441 191 14·2 (16·5) 1·00
(Enhanced 0·71–1·00 0·80 83086 192 15·9 (14·1) 1·16 (1·11–1·21)
vegetation 1·01–1·40 1·20 123799 173 12·4 (13·9) 1·25 (1·18–1·34)
Index) 1·41–3·00 2·20 159632 205 15·9 (15·4) 1·35 (1·24–1·47)
3·01–3·99 3·50 48238 184 13·9 (16·5) 1·40 (1·27–1·53)
a The last 2 characters denote the output from Fourier processing:−mn: minimum, a1: amplitude of annual cycle, a3:
amplitude of tri-annual cycle, p1: phase of annual cycle, p3: phase of tri-annual cycle.
b Odds Ratio (OR) was calculated for the reference point of the categories of each variable Xi from the ﬁnal model: Log
Odds=−2·67413 + βiXi. Where βiXi is: for country, −0·5203425×country_2−1·486901×country_3−1·627514×
country_4 (where the baseline country is France, and country_2, country_3 and country_4 are dummy variables for
country=Italy, Portugal or Spain, respectively); for altitude: 0·0015933×altitude−8·76×10−7×(altitude)2; for LSTNmn:
0·1632941×LSTNmn−0·0167179×(LSTNmn)2; for LSTNa3: 4·346963×LSTNa3−2·562916×(LSTNa3)2; for
EVIa1: 0·0874507×1/
√
EVIa1; for EVIp1: 0·136483×EVIp1−0·0361457×(EVIp1)2; and for EVIp3: −0·1942139×
(1/EVIp3).
c The 95% conﬁdence interval (CI) was calculated according to Pullan et al. (2008).
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model. Overall AUC statistics for the two extreme
seroprevalence classes (<5%, >20%) exceeded the 0·7
threshold for fair to good discrimination (AUC=0·77
and 0·81, respectively), but the AUC for the
intermediate class (5–20%) was below the threshold
(AUC=0·64).
Risk maps
The predicted CanL seroprevalence was mapped for
the four-country model (Fig. 2) and for the France-
only model (Fig. 3) using 5 endemicity classes. Pixels
were unclassiﬁed if their environmental values were
outside the range of those in the survey locations.
When estimating seroprevalence for the risk maps, a
minimum increment was added to each value of
EVIp3, EVIa1 and LSTNa2, in order to eliminate
any zero values. In the four-country model, EVIp3
and EVIa1 were replaced by EVIp3+0·01 and
EVIa1+0·001, respectively; and, in the France-only
model, LSTNa2 was replaced by LSTNa2+0·02.
Unclassiﬁed pixels were relatively few in number
for the four-country model, but considerably higher
for the France-only model. For the four-country
map, a total of 4034 (6·31%) pixels were unclassiﬁed
(Italy: 1969 (14·88%); Spain: 661 (3·12%); Portugal:
55 (1·47%)), with 1711 of these pixels being outside
the altitude range of the survey locations in the four
countries (254 <1m a.s.l.; 1457 >1838m a.s.l.),
and 50% of the unclassiﬁed pixels were located
<1492m a.s.l. For France mapped using the four-
country model, a total of 1349 (5·24%) pixels were
unclassiﬁed, with 575 of these pixels being outside
the altitude range of the survey locations in the four
countries (81<1m a.s.l.; 494 >1838m a.s.l.), and
50% of the unclassiﬁed pixels were located <1457m
a.s.l. In contrast, for France investigated by the
France-only model, a total of 7998 (31·05%) pixels
were unclassiﬁed, with 1333 of these pixels being
outside the altitude range of the survey locations in
France (81<1m a.s.l.; 1252 >1193m a.s.l.), and 50%
of the unclassiﬁed pixels were located <257m a.s.l.
Table 4. Multivariate binomial logistic regression analysis of the associations between seroprevalence of
canine leishmaniasis and each explanatory variable (or risk factor) for the France-only model
Explanatory
variable Category Ref. point
No. dogs
tested
No.
surveys
Mean
prevalence
(Standard
deviation) ORb (95% CI) c
Altitude 1–99 50 30444 48 13·2 (14·0) 1·00
100–249 175 3247 41 9·8 (7·8) 1·38 (1·15–1·67)
250–499 375 2751 36 11·1 (7·3) 1·91 (1·31–2·78)
500–1838 750 2121 39 6·8 (6·5) 2·91 (1·57–5·42)
LSTNmna −5·16–0·34 –3·00 3089 48 5·4 (4·9) 1·00
(Night-time −0·33–1·10 0·40 2660 42 7·4 (7·9) 2·10 (1·34–3·31)
land surface 1·11–2·30 1·70 3545 38 11·1 (7·2) 2·79 (1·49–5·22)
temperature) 2·31–4·66 3·50 29965 41 18·4 (12·7) 4·14 (1·74–9·83)
LSTNa2a 0·180–0·50 0·35 27794 32 17·4 (14·4) 1·00
(Night-time 0·510–0·66 0·60 2455 28 10·2 (7·4) 0·57 (0·42–0·76)
land surface 0·661–0·80 0·75 3195 40 9·7 (8·8) 0·46 (0·31–0·69)
temperature) 0·801–1·00 0·90 2566 38 6·2 (7·1) 0·40 (0·25–0·65)
1·010–2·24 1·50 3249 31 9·2 (6·5) 0·29 (0·15–0·55)
LSTNa3a 0·040–0·30 0·15 3343 38 8·8 (8·9) 1·00
(Night-time 0·301–0·37 0·35 3342 39 10·4 (7·3) 1·25 (1·02–1·55)
land surface 0·371–0·50 0·45 3221 39 8·5 (6·3) 1·40 (1·02–1·92)
temperature) 0·501–0·65 0·55 28276 30 18·3 (15·2) 1·57 (1·03–2·39)
0·651–1·54 1·15 1077 23 5·6 (5·3) 3·10 (1·08–8·87)
MIRa1a 0·0060–0·016 0·010 1980 35 7·7 (6·8) 1·00
(Middle 0·0161–0·019 0·017 2932 31 9·3 (6·9) 1·25 (1·08–1·46)
Infrared 0·0191–0·025 0·023 2807 35 10·0 (6·7) 1·52 (1·15–2·01)
reﬂectance) 0·0251–0·032 0·030 3049 34 9·8 (9·0) 1·90 (1·23–2·93)
0·0321–0·040 0·036 28491 34 14·9 (15·7) 2·31 (1·31–4·05)
MIRa3a 0·0005–0·0014 0·001 28139 29 20·3 (13·7) 1·00
(Middle 0·0015–0·0026 0·002 3461 32 12·6 (8·0) 0·87 (0·78–1·00)
Infrared 0·0027–0·0042 0·003 2800 37 8·0 (5·7) 0·77 (0·60–0·99)
reﬂectance) 0·0043–0·0056 0·005 2914 35 6·8 (7·9) 0·59 (0·36–0·98)
0·0057–0·0106 0·008 1945 36 6·1 (6·5) 0·40 (0·17–0·97)
a The last 2 characters denote the output from Fourier processing:−mn: minimum, a1: amplitude of annual cycle, a2:
amplitude of bi-annual cycle, a3: amplitude of tri-annual cycle.
b Odds Ratio (OR) was calculated for the reference point of the categories of each variable Xi from the ﬁnal model: Log
Odds=−5·849738 + βiXi. Where βiX is, for altitude: 0·0526301×√altitude; for LSTNmn: 0·2185278×LSTNmn; for
LSTNa3: 1·130128×LSTNa3; for LSTNa2: 1·429675×1/
√
LSTNa2; for MIRa1: 32·16849×MIRa1; and for MIRa3:
−129·4284×MIRa3.
c The 95% conﬁdence interval (CI) was calculated according to Pullan et al. (2008).
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Fig. 2. Risk map for canine leishmaniasis (CanL) in Portugal, Spain, France and Italy based on the
four-country model. Predicted CanL seroprevalence was mapped only for the pixels where the predictive
environmental values were within the range of those in the survey locations. Other pixels, those outside this mask, are
shaded in grey.
Fig. 3. Risk map for canine leishmaniasis (CanL) in France based on the France-only model. Predicted CanL
seroprevalence was mapped only for the pixels where the predictive environmental values were within the range
of those in the survey locations. Other pixels, those outside this mask, are shaded in grey. The areas marked by
red diagonals show France outside the latitudinal range of all the surveys analysed. Latitude was not a predictive
variable.
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For France, overall, there were almost 13 times more
pixels not classiﬁed at altitudes41193m a.s.l. in the
France-only risk map compared with the four-
country one.
DISCUSSION
Our database is unique. It is the ﬁrst time that
detailed historical records of CanL in endemic
European countries have been collated in this
standardized way for such a long period (1965–
2006), and the database is an important resource for
future eco-epidemiological analyses at country and
regional levels. However, like all such databases, its
entries mirror the diﬀerent histories of European
teams working with changing diagnostic techniques
and public health priorities (Dujardin et al. 2008),
including the period (1990–1998) when epidemiolo-
gical investigations of ZVL focused on co-infections
with HIV. Partly for these reasons, many records
were not suitable for our speciﬁc analyses, and we
hope this ﬁnding will prompt better standardization
of prospective surveys when cost eﬀective.
Our use of this database in the current report has
produced 2 sets of novel ﬁndings. One set arises from
the construction of the ﬁrst explicit risk map for
CanL in western Mediterranean Europe and con-
sideration of the lessons to be learned from its
apparent deﬁciencies. The second set of ﬁndings
relates to the identiﬁcation of shortcomings in the
scope and standardization of CanL surveys, and how
these can inform guidelines for future collection of
prospective data.
Our best model for western Europe, the four-
countrymodel, predicted the seroprevalence of CanL
based on 7 variables, namely country, altitude,
minimum night-time land surface temperature
(LSTNmn), amplitude of the tri-annual cycle of
the night-time land surface temperature (LSTNa3),
amplitude of the annual cycle of the Enhanced
vegetation index (EVIa1), phase of the annual cycle
of the Enhanced vegetation index (EVIp1) and phase
of the tri-annual cycle of the Enhanced vegetation
index (EVIp3). The association with CanL seropre-
valence was inversely U-shaped for 4 of the pre-
dictors (altitude, LSTNmn, LSTNa3, and to a lesser
degree EVIp1), and this can be explained by the
ecological requirements of the nocturnal sandﬂy
vectors being met in rural settings on the lower
and middle slopes of hills and mountains (often
100–800m a.s.l.) during the dryMediterranean sum-
mer (Ready, 2008; Gálvez et al. 2010a; Mahamdallie
et al. 2011). The more linear associations with EVIa1
and EVIp3 were negative and positive, respectively,
and these ﬁndings should be explored by sandﬂy
ecologists. There is no published risk map for
CanL in the western Mediterranean to compare
with our own. However, our risk map does appear
to be inconsistent with the incidence map of
Trotz-Williams and Trees (2003), principally by
not predicting more high risk areas near the coastal
plains of Spain and Portugal, and also by predicting
too many high risk areas in southwest, northwest
and central France. Chamaillé et al. (2010) used the
machine-learning Maxent method to produce an
ecological niche model and a risk map for CanL in
southern France, and this was based on presence data
from our database, including many records from
veterinary clinics. Our risk maps diﬀer from theirs by
identifyingmore low-high risk areas in central France
and the inland parts of southwest France, as well as by
identifying fewer medium-high risk areas in the more
coastal parts of southwest France, where the Atlantic
inﬂuences the climate.
One of the predictors of CanL in our four-country
model was country. It is often the case that models
diﬀer between nearby countries, and this is true for
anthroponotic visceral leishmanisis caused by
Leishmania donovani in East Africa (Ready, 2008).
Model variation between European countries might
be explained by geographical diﬀerences in climate
and seasonality associated with the bioclimatic and
ecological requirements of the sandﬂy species serving
as regional vectors. These considerations prompted
us to construct a separate model and risk map for
France, where both vectors (P. perniciosus and
P. ariasi) have overlapping altitudinal ranges
throughout much of the Mediterranean region
(Ready, 2008; Chamaillé et al. 2010; Hartemink
et al. 2011), unlike in Italy where 1 of the 2 main
vectors (P. perﬁliewi, notP. perniciosus) occurs only in
the centre-south of the country (Maroli et al. 2008).
Our best model for France alone, the France-only
model, predicted the seroprevalence of CanL based
on 6 variables, namely altitude, LSTNmn, ampli-
tude of the bi-annual cycle of the night-time land
surface temperature (LSTNa2), LSTNa3, ampli-
tude of the annual cycle of middle infrared reﬂectance
(MIRa1) and amplitude of the tri-annual cycle of
middle infrared reﬂectance (MIRa3). LSTNa2 and
MIRa3 were negatively associated with CanL sero-
prevalence, while the other 4 variables were positively
associated with it. The France-only model diﬀers
from the four-country model mainly in the replace-
ment of EVI, an index that estimates plant structural
variation based on the reﬂectance of red and near-
infrared wavelengths, with MIR, an index that
distinguishes better between active vegetation on
the one hand and senescent vegetation, soils, rocks or
anthropogenic surfaces on the other (Scharlemann
et al. 2008).
The France-only model was found to be better
than the four-country model for predicting the
seroprevalence of CanL in France, probably because
the latter was based mostly on surveys and dogs from
Italy (40% and 84%, respectively) rather than France
(18% and 7·8%, respectively). The four-country
model was a poor global predictor of point values of
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CanL seroprevalence (correlation coeﬃcient,
r=0·341), although the correlation was stronger for
survey-rich Italy (r=0·432) than for the other 3
countries (r=0·233–0·262). In comparison, the
France-only model gave a much better correlation
between the predicted and observed CanL seropre-
valences (r=0·648). Based on AUC statistics, both
models did provide fair-to-good discrimination
(AUC >0·7) for the 2 extreme classes of CanL
endemicity (<5%, >20% seroprevalence) but not for
the intermediate class (5–20%). Many observed
seroprevalences fell within this intermediate class
(360 out of 947 overall, and 84 out of 169 in France),
which is also true for much of the Mediterranean
region (Dujardin et al. 2008), and so it is important to
consider whether this lack of resolution results from
the modelling approach or inadequate sampling.
The statistical methods commonly used to predict
the occurrence or distribution of parasitic diseases in
relation to environmental variables include discrimi-
nant (Rogers and Randolph, 2006) and Bayesian
methods (Clements et al. 2006) as well as logistic
regression, both binary (Brooker et al. 2001) and
binomial (Rabe-Hesketh and Everitt, 2004). Binary
logistic regression was used successfully for the
spatial modelling of anthroponotic visceral leishma-
niasis in East Africa (Thomson et al. 1999). Non-
linear discriminant analysis (NLDA) might provide
better predictions than logistic regression (Rogers
and Randolph, 2006), and it would be interesting to
apply it to our datasets. However, we do not believe
that NLDA would much improve the resolution of
our predictions for those locations where CanL
seroprevalence is in the intermediate range of
5–20%. This conclusion stems from the limitations
of our climate and RS datasets as well as of the
sampling procedures used to obtain our survey data.
In common with most spatial models, ours relied on
using widely available sets of climate and RS data,
which unfortunately cover diﬀerent time periods and
have varying spatial resolutions. None of the resol-
utions fully captured the variation in the microcli-
mates inhabited by sandﬂies, which would hinder the
inclusion of sandﬂy density as an explanatory variable
in any integrated model (Hartemink et al. 2011). We
could have modelled CanL seroprevalence over
shorter time periods using matching climate surfaces
from the EU ENSEMBLES project (http://www.
ensembles-eu.org/), in order to improve the risk
maps and investigate any eﬀects of climate change.
However, this requires the availability of CanL
seroprevalence datasets with fewer limitations than
those currently available, as now explained.
Our models’ poor predictions of CanL sero-
prevalence in the intermediate range of 5–20% relate
to shortcomings in the scope and standardization
of CanL surveys. Firstly, there has been a bias
towards known rural and peri-urban foci in
Mediterranean bioclimate zones, and consequently
zero seroprevalence was recorded in only 14·7% of the
surveys (14–25% in France, Portugal and Spain, but
just 6% in Italy). We recommend that future surveys
do not neglect environments at more extreme
altitudes (<100m, >1000m a.s.l.) and northerly
latitudes. Secondly, the most used serological test
(IFAT) has not been standardized, e.g. the pro-
portion of surveys using a cut-oﬀ of <1/80 was 35·4%
in Italy and 19·2% in Portugal, but negligible in
Spain (2·4%) and France (0%). The use of low IFAT
cut-oﬀs in many surveys in Italy could possibly have
produced for this country the highest median
seroprevalence (17·7%; 5·9–8% elsewhere) and the
lowest frequency of zero seroprevalence (6%; 14–25%
elsewhere). We strongly recommend that all pub-
lished surveys include the proportion of dogs
seropositive for each of the serial dilutions of the
sera, not just for those making the cut-oﬀ, so that
records from diﬀerent periods can be better com-
pared. Improvements in ﬂuorescence microscopy
have led to changes in the consensus cut-oﬀ, ﬁrst
1/40 in the 1970s, then 1/80 in the 1990s, and
sometimes 1/160 recently. Thirdly, serology only
detects a small fraction of resistant dogs and the
susceptibles progressing to clinical disease after long
incubation (Maia and Campino, 2008). Therefore,
ideally, serology should be complemented by mol-
ecular screening in horizontal surveys (Lachaud et al.
2002; Quinnell and Courtenay, 2009). Lastly, the
resolution of the sampling is inadequate, because
a point location was very often an assembly point in a
large village, to which dogs were brought for screen-
ing from a radius of 10 km or more (Rioux and
Golvan, 1969; Maroli et al. 2008; Martín-Sánchez
et al. 2009; Gálvez et al. 2010b). To improve the
sampling resolution, we recommend including in the
model ‘dog factors’, such as the age and lifestyle of
individual dogs recorded as living most of the time in
speciﬁc geo-referenced habitations. Concerning life-
style, guard dogs and hunting dogs often have a
higher prevalence of CanL than pet dogs that sleep
indoors (Lanotte et al. 1978; Martín-Sánchez et al.
2009; Gálvez et al. 2010b). A potentially important
explanatory variable missing from our modelling is
dog density. Estimates have been used for ecological
niche modelling (Chamaillé et al. 2010) and R0
modelling (Hartemink et al. 2011) of CanL or its
vectors in southern France, but these estimates of dog
density were based on human population densities
that were low and varied little per km2 in the rural
areas characteristic of CanL.
As a result of these shortcomings, our risk maps
can not be expected to have much predictive power
within many CanL foci. It might not always be cost
eﬀective to produce high resolution risk maps
within CanL foci, for which it will be necessary to
follow all our recommendations, but the conse-
quences of not doing so ought to be assessed when
agreeing guidelines for collecting prospective data. In
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contrast, it should be less challenging to improve
spatial models so that diﬀerent geographical regions
can be compared. Then, our relatively straightfor-
ward method of producing risk maps would be more
useful for predicting any northward emergence of
CanL and helping to plan barrier methods of control,
based currently on topical insecticides (deltamethrin-
impregnated dog collars and pour-ons) not dog
culling (Quinnell and Courtenay, 2009) and hope-
fully on vaccines (Ready, 2010). Already, we have
demonstrated that country-level risk maps can
distinguish well between areas with high (>20%)
and low (<5%) CanL seroprevalences (only 3%
misclassiﬁed using the France-only model) and that
seroprevalences are invariably low in areas of CanL
emergence. For example, seroprevalence is usually
<5% throughout northern Italy above latitude 45·50
N, where CanL has emerged within the last 20 years
(Maroli et al. 2008). The improvement of spatial
models for predicting CanL emergence in Europe
depends on carrying out new standardized serological
and molecular surveys in central and northern
Europe as well as at extreme altitudes (<100m,
>1000m a.s.l.) in Mediterranean locations with
comparable land covers. Without such sampling,
predictions will not be possible for many regions of
interest, such as much of France above 47·50 N,
which is the approximate northern limit of our
records and of the risk map produced by ecological
niche modelling (Chamaillé et al. 2010). The com-
plexities of predicting the eﬀects of climate change
(Kovats et al. 2001) lessen the likelihood of risk maps
being used to predict the spread of CanL in response
to global warming.
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